A USA-based CRO company was looking for Regulatory support in the initial filing of an IND submission to the USFDA. The client’s project presented several challenges such as stringent deadlines, working with large volumes of documents, and reviewing all the source documents for additional questions. Freyr’s talent pool provided a valid submission with zero errors and warnings from the Agency by dedicating full-time resources and validating the documents using industry-accepted tools for publishing activities.

Know more about how Freyr helped the client meet their business objective in defined timelines and ensured the filing of a valid initial IND submission to the USFDA with zero errors. Download the proven case.